KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Gains from Investment Securities (2017 - 2026)

Johnson & Johnson's Gains from Investment Securities history spans 18 years, with the latest figure at $54.0 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 80.0% to $54.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $186.0 million, a 6.53% decrease, with the full-year FY2025 number at $162.0 million, down 6.9% from a year prior.
  • Gains from Investment Securities hit $54.0 million in Q1 2026 for Johnson & Johnson, down from $63.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for JNJ hit a ceiling of $111.0 million in Q4 2023 and a floor of -$185.0 million in Q1 2023.
  • Historically, Gains from Investment Securities has averaged $16.8 million across 5 years, with a median of $33.0 million in 2025.
  • Biggest five-year swings in Gains from Investment Securities: crashed 85.59% in 2024 and later surged 500.0% in 2025.
  • Tracing JNJ's Gains from Investment Securities over 5 years: stood at $59.0 million in 2022, then crashed by 276.27% to -$104.0 million in 2023, then soared by 169.23% to $72.0 million in 2024, then fell by 12.5% to $63.0 million in 2025, then dropped by 14.29% to $54.0 million in 2026.
  • Business Quant data shows Gains from Investment Securities for JNJ at $54.0 million in Q1 2026, $63.0 million in Q4 2025, and $33.0 million in Q3 2025.